Jacob "Jack" J.H. Bleesing, MD, PhD

Clinical Characteristics, Management, and Hematopoietic Cell Transplantation of Patients with TLR8 Gain-of-Function. Arnold, DE; Kaviany, S; Aluri, J; Calvo, KR; Mehta, SS; Tobin, JM; Schuettpelz, L; Saucier, N; Schmitz, EG; Murguía-Favela, L; Pai, S-Y; Bednarski, JJ; Connelly, JA; Cooper, MA. Blood advances. 2025.

Hematopoietic Cell Transplantation for Wiskott-Aldrich syndrome: A PIDTC Report. Alexander, JL; Dávila Saldaña, BJ; Brazauskas, R; Dammalapati, SG; Griffith, LM; Shah, AJ; Shimano, KA; Ochs, HD; Bleesing, J; Ebens, CL; Cowan, MJ; Petrovic, A; Pai, S-Y; Burroughs, LM. Blood advances. 2025.

B-252 Functional Validation of Novel FAS Intronic and Splice Region VUS Through Minigene Assays. Zhang, W; Wen, K; Bleesing, J; Xin, M. Clinical Chemistry. 2025; 71(Supplement_1):hvaf086.640.

Lipopolysaccharide-responsive and beige-like anchor protein (LRBA) functional deficiency caused by biallelic LRBA missense variants characterized by Evans syndrome or colitis. Chiang, SCC; Yang, L; Owsley, E; Husami, A; Akeno, N; Cobb, C; Hartog, NL; Elizalde, A; Seroogy, CM; Blanchard-Rohner, G; Marsh, R; Bleesing, J; Jordan, MB; Marwaha, AK. Journal of Allergy and Clinical Immunology. 2025; 156(2):270-278.

Factors associated with and kinetics of anti-IFN-α autoantibodies in RAG1/2 deficiency. Wang, C; Potts, DE; Sun, B; Toth, M; Ujhazi, B; Sharapova, S; Miller, R; Rosen, L; Yilmaz, M; Larsen, K; Strauss, KA; Holland, SM; Notarangelo, LD; Walter, JE. Journal of Allergy and Clinical Immunology: Global. 2025; 4(3):100521.

A Novel Dominant Negative Variant in IL2RG Gene that Failed to Be Corrected by Lentiviral Gene Therapy. Hussain, M; Nagarsheth, N; Jones, J; Bleesing, J; Chandra, S; Marsh, R; Dansereau, C; O'donnell, M; Silva, O; Kerwin, B; De Ravin, SS; Prockop, S; Williams, D; Pai, S-Y. Journal of Human Immunity. 2025; 1(CIS2025).

Precision Alemtuzumab Dosing Results in Day 0 Target Range Achievement in 80% of IEI Patients and Minimizes Risks of GVHD, Clinically Significant Mixed Chimerism, and Secondary Graft Failure. Marsh, R; Khoury, R; Mizuno, K; Hosawi, A; Cottrell, C; Nguyen, E; Landon, B; Chandra, S; Jordan, M; Kumar, A; Bleesing, J; Davies, S; Moore, C; Mehta, P. Journal of Human Immunity. 2025; 1(CIS2025).

Addition of Thiotepa to Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Reduces Secondary Graft Failure in Allogeneic HSCT for Inborn Errors of Immunity. Khoury, R; Jordan, M; Bleesing, J; Kumar, A; Saldana, BD; Verkamp, B; Davies, S; Marsh, R; Chandra, S. Journal of Human Immunity. 2025; 1(CIS2025).

Validation of an Interferon Type I Score Test on the Nanostring nCounter Platform. Chiang, S; Yang, L; Akeno, N; Owsley, E; De Jesus, A; Goldbach-Mansky, R; Marsh, R; Bleesing, J. Journal of Human Immunity. 2025; 1(CIS2025).

Clinical and Analytical Validation of a NOD2 Functional Test for XIAP/XLP2 Diagnosis. Chiang, S; Akeno, N; Owsley, E; Verbsky, J; Ibrahimova, A; Bleesing, J; Marsh, R. Journal of Human Immunity. 2025; 1(CIS2025).